GlobeNewswire by notified

Philips and County Durham and Darlington NHS Foundation Trust collaborate on a sustainability blueprint to reduce carbon emissions and waste

Share

November 2, 2023

Amsterdam, the Netherlands and Farnborough, UK –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology and County Durham and Darlington NHS Foundation Trust (CDDFT), one of the largest integrated care providers in England, today announced the results of a comprehensive 360 sustainability analysis. The program identified key opportunities to reduce the carbon footprint and waste material within the intensive care unit (ICU) at Darlington Memorial Hospital. Understood to be the first sustainability collaboration of its kind within the NHS, the program illustrates the growing demand for ‘greener’ services in the healthcare sector and showcases the potential for health systems around the world to transform critical care pathways and embed sustainability within their operations.

“Philips took time to undertake quantitative analysis which validated our suspicions and provided outputs we could present back to the wider Trust. The quality of care we provide on the unit has gone up because of the work, as well as through the direct way we serve certain groups of patients,” said Dr. Richard Hixson, Consultant in Anesthesia and Critical Care Medicine at CDDFT. “For example, by looking at patient flow and de-medicalization of patients, we are helping to ease demand on critical care by adjusting medication, removing monitoring that is no longer required and moving patients onto new pathways, in a positive way.”

ICUs are at the center of diverse clinical practices and in the UK, represent a significant portion of the carbon footprint, while also being one of the most expensive types of care. The analysis, developed as part of the existing 14-year strategic agreement between Philips and the Trust, supports its aims to become a leading example for environmental sustainability in human healthcare.

A team of nine clinical and environmental specialists from Philips worked with the Trust over six months to identify efficiency improvements, with the potential to reduce the carbon footprint of a critical care department. The team analyzed data, interviewed clinical staff including physicians and nurses and undertook shadowing and observation sessions. These focused on clinical workflow, supply chain and procurement, medical technology, and staff and patient experience. The results form a blueprint to drive further change and improvement across the Trust, in line with the NHS’s overall target of being the world’s first net zero national health service by 2040.

The key areas highlighted by the team for enhancing sustainable care were:

  • Optimizing ICU capacity for earlier patient discharge, freeing up resources, improving health outcomes, and reducing the carbon footprint
  • Reducing supply chain waste, including high CO2 impact single-use items, and promoting cost savings and eco-friendly alternatives
  • Cultivating a sustainable staff culture through training, identifying ambassadors, idea sharing, success measurement, and staff recognition
  • Efficient management of medical technology to conserve power, reduce waste, and minimize disruptive noise from patient alarms
  • Strategically refurbishing existing buildings to cut costs and CO2 emissions by extending their lifespan

Following the analysis, the Trust has implemented a number of recommended initiatives. For more information, read the full case study “Working Together to Green Critical Care”.

Mark Leftwich, Managing Director at Philips UK&I: “Healthcare providers have a responsibility to safeguard both our well-being and our environment, with climate change and human health working hand in hand. This first of kind partnership between Philips and County Durham and Darlington NHS Foundation Trust is an important milestone in the race to reach net zero and provide more sustainable care. As the first 360 sustainability assessment for the NHS, this collaboration shows the potential of finding solutions that care for patients, our health workforce, and the planet all at once, helping to create more resilient health systems for the future."

This program with CDDFT follows similar analyses conducted by Philips at Tampere Heart Hospital (Tampere, Finland), Vanderbilt University Medical Center (Nashville, USA) and Champalimaud Foundation (Lisbon, Portugal). 

Philips has operated globally carbon-neutral since 2020, embedding EcoDesign principles and circular business models into its innovation processes and ways of working. The company offers a range of health technologies and innovations that help reduce healthcare providers’ impact on the environment. For example, its Philips Spectral CT 7500 uses 62.5% less energy [1], and the Philips MR – Ingenia Ambition 1.5T, which uses a breakthrough design where the magnetic components are completely sealed and only need seven liters of helium over its lifetime compared to roughly 1,500 liters with other Philips systems [2]. Additionally, with Philips MR SmartSpeed, the Ingenia Ambition 1.5T uses up to 53% less power per patient scan [2].

[1] When compared to an equivalent CT model of one of the industry leaders
[2] Applicable to Ambition S. Philips SmartSpeed power consumption versus Philips SENSE-based scanning. Based on COCIR and an in-house simulated environment. Results can vary based on site conditions.

For further information, please contact:


Joost Maltha
Philips Global Press Office
Tel. : +31 6 10558116
E-mail : joost.maltha@philips.com

Dominique Monaghan
Philips UK&I
E-mail : dominique.monaghan@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 70,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About County Durham and Darlington NHS Foundation Trust
The Trust is one of the largest integrated care providers in England, employing over 7,000 members of staff and serving a population of over 650,000 people, and as such recognises its key role to play in reducing carbon emissions and supporting the local community to adapt to climate change.

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nokia unveils plans for new state-of-the-art research and development facility for Nokia Bell Labs in New Brunswick, New Jersey technology hub11.12.2023 16:30:00 CET | Press release

Press Release Nokia unveils plans for new state-of-the-art research and development facility for Nokia Bell Labs in New Brunswick, New Jersey technology hub Nokia Bell Labs is reaffirming its commitment to New Jersey, upholding its 80-year heritage of cutting-edge research and innovation in the state.Move will establish New Brunswick as Nokia’s new R&D hub on the East Coast and affirms Nokia’s commitment to this fast-growing innovation zone in the US. 11 December 2023 New Brunswick, New Jersey – Nokia today announced plans to relocate its campus in Murray Hill, NJ by 2028 to a new state-of-the-art research and development (R&D) facility in the burgeoning innovation and technology hub in New Brunswick, NJ. The new leading-edge R&D facility will propel Nokia Bell Labs to adapt and evolve to remain at the forefront of cutting-edge technology and continue contributing to a legacy of innovation in New Jersey. As the industrial research arm of Nokia, Nokia Bell Labs has always moved ahead of

Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties11.12.2023 16:30:00 CET | Press release

Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties Pursuant to article 19 of the EU Regulation 596/2014 and according to a power of attorney given by Anne Mette Toftegaard, Alm. Brand A/S is required to file information on trading in shares in Alm. Brand A/S or other securities related to these shares by executives and their related parties. Please see attached report. Contact Please direct any questions regarding this announcement to: Senior Investor Relations Officer Mikael Bo Larsen, Mobile no. +45 51 43 80 02 Attachment AS 26 2023 - Report on trading Anne Mette Toftegaard

Nokia launches new venture partnerships and venture studio to maximize commercial potential of Nokia Bell Labs’ innovations11.12.2023 16:30:00 CET | Press release

Press Release Nokia launches new venture partnerships and venture studio to maximize commercial potential of Nokia Bell Labs’ innovations Nokia Innovation Framework evolving with new venture studio and venture partnerships to unleash the full commercial potential of Nokia Bell Labs technologies outside of Nokia’s strategic perimeters. A new venture studio with America’s Frontier Fund and Roadrunner Venture Studios for commercializing the next generation of critical technology for the US will be situated in New Jersey, the iconic home of Bell Labs innovation for over 80 years.New venture partnership with Celesta Capital will invest in scaling ventures built with deep technologies from Nokia Bell Labs. 11 December 2023 Murray Hill, New Jersey – Nokia today announced an evolution to its Innovation Framework to unlock the full commercial potential of Nokia Bell Labs’ innovations across industries and expand efforts in external startup creation in the US with new partnerships and a new vent

Alm. Brand - Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Alm. Brand A/S aktier11.12.2023 16:30:00 CET | pressemeddelelse

Alm. Brand - Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Alm. Brand A/S aktier I henhold til EU-forordning 596/2014 artikel 19 og i henhold til fuldmagt til at indberette handler for Anne Mette Toftegaard skal Alm. Brand A/S hermed indberette oplysninger om ledende medarbejderes og disses nærtståendes transaktioner med Alm. Brand A/S aktier eller andre værdipapirer, som er knyttet til disse aktier. Se vedhæftede indberetning. Kontakt Eventuelle henvendelser vedrørende denne fondsbørsmeddelelse bedes rettet til Senior Investor Relations Officer Mikael Bo Larsen, mobil 51 43 80 02. Vedhæftet fil AS 26 2023 - Indberetning af transaktioner Anne Mette Toftegaard

Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties11.12.2023 16:30:00 CET | Press release

Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties Pursuant to article 19 of the EU Regulation 596/2014 and according to a power of attorney given by Rasmus Werner Nielsen, Alm. Brand A/S is required to file information on trading in shares in Alm. Brand A/S or other securities related to these shares by executives and their related parties. Please see attached report. Contact Please direct any questions regarding this announcement to: Senior Investor Relations Officer Mikael Bo Larsen, Mobile no. +45 51 43 80 02 Attachment AS 25 2023 - Report on trading_Rasmus Werner Nielsen